-
Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors
Author: Wei, Chen; Wang, Mengyu; Gao, Quanli; Yuan, Shasha; Deng, Wenying; Bie, Liangyu; Ma, Yijie; Zhang, Chi; Li, Shuyi; Luo, Suxia; Li, Ning
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 23-37. DOI: 10.1007/s00262-022-03221-5
-
Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer
Author: Ding Jianyi; Gan Haili; Bo, Yin; Yang Meiqin; Huang Baoyou; Hu Haoran; Li Fang; Zheng Qingliang; Han Lingfei
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 73-85. DOI: 10.1007/s00262-022-03226-0
-
Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint
Author: Lei, Jie; Zhu, Jianfei; Hui, Bengang; Jia, Chenghui; Yan, Xiaolong; Jiang, Tao; Wang, Xiaoping
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 101-124. DOI: 10.1007/s00262-022-03235-z
-
Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer
Author: Ji, Niannian; Long, Meijun; Garcia-Vilanova, Andreu; Ault, Russell; Moliva, Juan, I; Yusoof, Kizil A.; Mukherjee, Neelam; Curiel, Tyler J.; Dixon, Hong; Torrelles, Jordi B.; Svatek, Robert S.
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 125-136. DOI: 10.1007/s00262-022-03236-y
-
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer
Author: Nose, Yohei; Saito, Takuro; Yamamoto, Kei; Yamashita, Kotaro; Tanaka, Koji; Yamamoto, Kazuyoshi; Makino, Tomoki; Takahashi, Tsuyoshi; Kawashima, Atsunari; Haruna, Miya; Hirata, Michinari; Ueyama, Azumi; Iwahori, Kota; Satoh, Taroh; Kurokawa, Yukinori; Eguchi, Hidetoshi; Doki, Yuichiro; Wada, Hisashi
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 169-181. DOI: 10.1007/s00262-022-03240-2
-
TIGIT blockade enhances tumor response to radiotherapy via a CD103+dendritic cell-dependent mechanism
Author: Zhao, Kaikai; Jiang, Liyang; Si, Youjiao; Zhou, Shujie; Huang, Zhaoqin; Meng, Xiangjiao
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 193-209. DOI: 10.1007/s00262-022-03227-z
-
Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis
Author: Lv, Liwei; Wu, Yuchen; Shi, Han; Sun, Xuefei; Deng, Zixin; Huo, Hongjia; Li, Ruonan; Liu, Yuanbo
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 211-221. DOI: 10.1007/s00262-022-03246-w
-
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis
Author: Jiang, Guangyi; Ng, Yu Yang; Tay, Johan C. K.; Du, Zhicheng; Xiao, Lin; Wang, Shu; Zhu, Jianqing
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2023; Vol. 72, Issue 1, pp. 223-234. DOI: 10.1007/s00262-022-03247-9
